PRENTISS SMITH & CO INC - ISIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
PRENTISS SMITH & CO INC ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$7,000
+40.0%
2000.0%0.00%
+33.3%
Q2 2016$5,000
-37.5%
2000.0%0.00%
-40.0%
Q1 2016$8,000
-33.3%
2000.0%0.01%
-16.7%
Q4 2015$12,000
+50.0%
2000.0%0.01%
+50.0%
Q3 2015$8,000
-33.3%
2000.0%0.00%
-33.3%
Q2 2015$12,000
-7.7%
2000.0%0.01%0.0%
Q1 2015$13,000
+8.3%
2000.0%0.01%0.0%
Q4 2014$12,000
+50.0%
2000.0%0.01%
+50.0%
Q3 2014$8,000
+14.3%
2000.0%0.00%0.0%
Q2 2014$7,000
-22.2%
2000.0%0.00%
-20.0%
Q1 2014$9,000
+12.5%
2000.0%0.01%
+25.0%
Q4 2013$8,0000.0%2000.0%0.00%0.0%
Q3 2013$8,000
+60.0%
2000.0%0.00%
+33.3%
Q2 2013$5,0002000.00%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BB BIOTECH AG 6,417,548$255,675,00013.66%
HWG Holdings LP 339,799$13,538,0008.73%
DOWLING & YAHNKE LLC 675,798$26,924,0003.78%
GARRISON BRADFORD & ASSOCIATES INC 99,300$3,956,0003.74%
WILLIAM HARRIS INVESTORS INC 283,834$11,308,0003.35%
SECTORAL ASSET MANAGEMENT INC 1,222,401$48,700,0002.10%
AVALON CAPITAL MANAGEMENT 49,999$1,992,0001.68%
PINNACLE ASSOCIATES LTD 2,016,369$80,332,0001.57%
PERKINS CAPITAL MANAGEMENT INC 48,515$1,933,0001.30%
NCM Capital Advisers, Inc. 31,100$1,239,0001.28%
View complete list of ISIS PHARMACEUTICALS INC shareholders